Works matching AU Yu, Jung Hwan


Results: 31
    1
    2
    3

    Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 196, doi. 10.1111/apt.15741
    By:
    • Lee, Han Ah;
    • Lee, Hyun Woong;
    • Kim, In Hee;
    • Park, Soo Young;
    • Sinn, Dong Hyun;
    • Yu, Jung Hwan;
    • Seo, Yeon Seok;
    • Um, Soon Ho;
    • Lee, Jung Il;
    • Lee, Kwan Sik;
    • Lee, Chang Hun;
    • Tak, Won Young;
    • Kweon, Young Oh;
    • Kang, Wonseok;
    • Paik, Yong‐Han;
    • Lee, Jin‐Woo;
    • Suh, Sang Jun;
    • Jung, Young Kul;
    • Kim, Beom Kyung;
    • Park, Jun Yong
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 10, p. 1052, doi. 10.1111/jvh.13316
    By:
    • Lim, Tae Seop;
    • Lee, Hyun Woong;
    • Lee, Jung Il;
    • Kim, In Hee;
    • Lee, Chang Hun;
    • Jang, Byoung Kuk;
    • Chung, Woo Jin;
    • Yim, Hyung Joon;
    • Suh, Sang Jun;
    • Seo, Yeon Seok;
    • Lee, Han Ah;
    • Yu, Jung Hwan;
    • Lee, Jin‐Woo;
    • Kim, Sang Gyune;
    • Kim, Young Seok;
    • Park, Soo Young;
    • Tak, Won Young;
    • Kim, Soon Sun;
    • Cheong, Jae Youn;
    • Jeong, Soung Won
    Publication type:
    Article
    29
    30
    31